Stay updated with breaking news from Markets Insight. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An ongoing phase 3 clinical trial of SGT-610 for Gorlin Syndrome with the first patient screened; Results are expected by the end of 2025 Sol-Gel ...
(2024-03-13 | NDAQ:SLGL) Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
RHB-107 included in the U.S. Department of Defense-supported ACESO PROTECT multinational platform trial for early COVID-19 outpatient treatment; The...
Four leading specialty pharmacies honored for their dedication to the highest quality customer service...
Atlanta, GA (PRWEB) April 20, 2023 -- Global law firm Greenberg Traurig, LLP sponsored the 2nd Annual Emory Real Estate Conference April 14 at the Whitley